1,4-Dithiothreitol structure
|
Common Name | 1,4-Dithiothreitol | ||
---|---|---|---|---|
CAS Number | 16096-97-2 | Molecular Weight | 154.251 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 364.5±42.0 °C at 760 mmHg | |
Molecular Formula | C4H10O2S2 | Melting Point | 42-44ºC | |
MSDS | Chinese USA | Flash Point | 174.2±27.9 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of 1,4-DithiothreitolL-Dithiothreitol is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
Name | L-1,4-dithiothreitol |
---|---|
Synonym | More Synonyms |
Description | L-Dithiothreitol is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
---|---|
Related Catalog |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 364.5±42.0 °C at 760 mmHg |
Melting Point | 42-44ºC |
Molecular Formula | C4H10O2S2 |
Molecular Weight | 154.251 |
Flash Point | 174.2±27.9 °C |
Exact Mass | 154.012222 |
PSA | 118.06000 |
LogP | 0.07 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.579 |
Storage condition | −20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H312-H315-H319-H335 |
Precautionary Statements | P261-P280-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn: Harmful; |
Risk Phrases | R21/22 |
Safety Phrases | 26-36/37 |
RIDADR | UN 3335 |
WGK Germany | 3 |
RTECS | EK1612000 |
Hazard Class | 9.0 |
HS Code | 2930909090 |
~82% 1,4-Dithiothreitol CAS#:16096-97-2 |
Literature: Lee, Sang Hyup; Kohn, Harold Heterocycles, 2003 , vol. 60, # 1 p. 47 - 56 |
Precursor 1 | |
---|---|
DownStream 0 |
HS Code | 2930909090 |
---|---|
Summary | 2930909090. other organo-sulphur compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.
Cancer Prev. Res. (Phila.) 8(3) , 208-21, (2015) Exposure to toxicants leads to cumulative molecular changes that overtime increase a subject's risk of developing urothelial carcinoma. To assess the impact of arsenic exposure at a time progressive m... |
|
The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells.
PLoS ONE 9(5) , e97697, (2014) Patients with ER/HER2-positive breast cancer have a poor prognosis and are less responsive to selective estrogen receptor modulators; this is presumably due to the crosstalk between ER and HER2. Fatty... |
|
Matrix stiffening and β1 integrin drive subtype-specific fibroblast accumulation in lung cancer.
Mol. Cancer Res. 13(1) , 161-73, (2015) The crucial role of tumor-associated fibroblasts (TAF) in cancer progression is now clear in non-small cell lung cancer (NSCLC). However, therapies against TAFs are limited due to a lack of understand... |
Cleland reagent chiral |
2,3-Butanediol, 1,4-dimercapto-, (2R,3R)-rel- |
(2R,3R)-1,4-Disulfanyl-2,3-butanediol |
1,4-Dithiothreitol |
L-(−)-Dithiothreitol |
1,4-Bissulfanylbutane-2,3-diol |
DL-1,4-Dimercapto-2,3-dihydroxybutane |
(2R,3R)-(-)-2,3-Dihydroxy-1,4-butanedithiol |
1,4-Disulfanyl-2,3-butanediol |
(R*,R*)-1,4-DIMERCAPTO-2,3-BUTANEDIOL |
(2R,3R)-1,4-Disulfanylbutane-2,3-diol |
2,3-Butanediol, 1,4-dimercapto-, (2R,3R)- |
L-Dithiothreitol |
EINECS 240-263-0 |
(2R*,3S*)-1,4-dimercaptobutane-2,3-diol |
dithiothreitol |
threo-2,3-Dihydroxy-1,4-butanedithiol |
(−)-Cleland's Reagent |
(2R*,3S*)-1,4-dimercapto-2,3-butanediol |
(2R,3R)-(-)-1,4-Dimercapto-2,3-butanediol |
(2R,3R)-1,4-Dimercapto-2,3-butanediol |
UNII:T8ID5YZU6Y |
L-Cleland's |
1,4-Disulfanylbutane-2,3-diol |
2,3-Butanediol, 1,4-dimercapto- |
(±)-1,4-Dimercapto-2,3-butanediol |
(2R,3R)-1,4-dimercaptobutane-2,3-diol |
MFCD00064305 |